Mamatha Pasnoor

6.5k total citations · 1 hit paper
83 papers, 1.7k citations indexed

About

Mamatha Pasnoor is a scholar working on Neurology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Mamatha Pasnoor has authored 83 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Neurology, 16 papers in Physiology and 11 papers in Cellular and Molecular Neuroscience. Recurrent topics in Mamatha Pasnoor's work include Myasthenia Gravis and Thymoma (29 papers), Peripheral Neuropathies and Disorders (23 papers) and Botulinum Toxin and Related Neurological Disorders (14 papers). Mamatha Pasnoor is often cited by papers focused on Myasthenia Gravis and Thymoma (29 papers), Peripheral Neuropathies and Disorders (23 papers) and Botulinum Toxin and Related Neurological Disorders (14 papers). Mamatha Pasnoor collaborates with scholars based in United States, Canada and Japan. Mamatha Pasnoor's co-authors include Mazen M. Dimachkie, Richard J. Barohn, Patricia M. Kluding, Constantine Farmakidis, Laura Herbelin, Neena K. Sharma, Richard J. Barohn, Douglas E. Wright, Rupali Singh and Stephen Jernigan and has published in prestigious journals such as Neurology, Diabetes and Stroke.

In The Last Decade

Mamatha Pasnoor

77 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Long-term safety, tolerability, and efficacy of efgartigimod (ADAPT+): interim results from a phase 3 open-label extension study in participants with generalized myasthenia gravis

2024 36 citations James F. Howard, Vera Bril et al. profile →

Peers

Countries citing papers authored by Mamatha Pasnoor

Since Specialization

Citations

This map shows the geographic impact of Mamatha Pasnoor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mamatha Pasnoor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mamatha Pasnoor more than expected).

Fields of papers citing papers by Mamatha Pasnoor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mamatha Pasnoor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mamatha Pasnoor. The network helps show where Mamatha Pasnoor may publish in the future.

Co-authorship network of co-authors of Mamatha Pasnoor

This figure shows the co-authorship network connecting the top 25 collaborators of Mamatha Pasnoor. A scholar is included among the top collaborators of Mamatha Pasnoor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mamatha Pasnoor. Mamatha Pasnoor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pragmatic Clinical Trials in Neurology 2025 ·Annals of Neurology ·Adnan I. Qureshi, (unknown), Alexandra R. Brown, James C. McClay, Mamatha Pasnoor, Richard J. Barohn	1
2	Myasthenia gravis 2024 ·Handbook of clinical neurology ·Mamatha Pasnoor, Gil I. Wolfe, Richard J. Barohn	2
3	Resistance exercise in early-stage ALS patients, ALSFRS-R, Sickness Impact Profile ALS-19, and muscle transcriptome: a pilot study 2024 ·Scientific Reports ·Omar Jawdat, (unknown), (unknown), (unknown), Jeffrey Statland, Mamatha Pasnoor, Mazen M. Dimachkie, Carla Sabus, Yomna Badawi, Suzanne Hunt, (unknown), Sumedha Gunewardena, Clark Bloomer, Heather Wilkins, Laura Herbelin, Richard J. Barohn, Hiroshi Nishimune	3
4	Phase 2 trial in acetylcholine receptor antibody‐positive myasthenia gravis of transition from intravenous to subcutaneous immunoglobulin: The MGSCIg study 2023 ·European Journal of Neurology ·Mamatha Pasnoor, Vera Bril, Todd Levine, Jaya Trivedi, Nicholas J. Silvestri, Milind A. Phadnis, Hans Katzberg, David Saperstein, Gil I. Wolfe, Laura Herbelin, (unknown), Andrew Heim, Jeffrey Statland, Richard J. Barohn, Mazen M. Dimachkie	2
5	Conducting a bayesian multi-armed trial with response adaptive randomization for comparative effectiveness of medications for CSPN 2023 ·Contemporary Clinical Trials Communications ·Alexandra R. Brown, Byron J. Gajewski, Dinesh Pal Mudaranthakam, Mamatha Pasnoor, Mazen M. Dimachkie, Omar Jawdat, Laura Herbelin, Matthew S. Mayo, Richard J. Barohn	0
6	Hyaluronidase‐facilitated subcutaneous immunoglobulin 10% as maintenance therapy for chronic inflammatory demyelinating polyradiculoneuropathy: The ADVANCE‐CIDP 1 randomized controlled trial 2023 ·Journal of the Peripheral Nervous System ·Vera Bril, Robert D. M. Hadden, Thomas H. Brannagan, Michal Bar, Elisabeth Chroni, Konrad Rejdak, (unknown), Henning Andersen, Norman Latov, Todd Levine, Mamatha Pasnoor, Sabrina Sacconi, Nizar Souayah, Colin Anderson‐Smits, (unknown), Erin Greco, (unknown), Zhaoyang Li, Leman Yel, Hakan Ay	14
7	P277 Long-term safety, tolerability, and efficacy of Efgartigimod in patients with Generalized Myasthenia Gravis: concluding analyses from the ADAPT+ study 2023 ·Neuromuscular Disorders ·Elizabeth E. Ashcraft, Vera Bril, Mamatha Pasnoor, Chafic Karam, Stojan Perić, Jan De Bleecker, Hiroyuki Murai, Andreas Meisel, Said R. Beydoun, Tuan Vu, Peter Ulrichts, (unknown), Caroline T'joen, Kimiaki Utsugisawa, Jan J.G.M. Verschuuren, Renato Mantegazza, J. A. Howard	1
8	Quantifying Treatment-Related Fluctuations in CIDP 2021 ·Neurology ·Jeffrey A. Allen, Mamatha Pasnoor, Mazen M. Dimachkie, Senda Ajroud‐Driss, Thomas H. Brannagan, (unknown), (unknown), Mark Fiecas, John T. Kissel, Ingemar S. J. Merkies, Kenneth C. Gorson, Richard A. Lewis	20
9	Methotrexate Polyglutamation in a Myasthenia Gravis Clinical Trial 2020 ·Kansas Journal of Medicine ·Mamatha Pasnoor, Andrew Heim, Laura Herbelin, Jeffrey Statland, Mazen M. Dimachkie, Mara L. Becker, Richard J. Barohn	3
10	Retrospective longitudinal assessment of MG-ADL score with treatment of myasthenia gravis (P5.4-039) 2019 ·Neurology ·(unknown), Mamatha Pasnoor, (unknown), Suzanne Hunt, Omar Jawdat, Constantine Farmakidis, Duaa Jabari, Melanie Glenn, Jeffrey Statland, Richard J. Barohn, Mazen M. Dimachkie	1
11	Patient Assisted Intervention for Neuropathy: Comparison of treatment in real life situations (PAIN-CONTRoLS) (P1.435) 2018 ·Neurology ·Richard J. Barohn, Byron J. Gajewski, Mamatha Pasnoor, (unknown), Laura Herbelin, Kim S. Kimminau, Omar Jawdat, Tina Liu, (unknown), (unknown), Mazen M. Dimachkie, (unknown)	4
12	Treatment of Myasthenia Gravis 2018 ·Neurologic Clinics ·Constantine Farmakidis, Mamatha Pasnoor, Mazen M. Dimachkie, Richard J. Barohn	162
13	Rituximab as treatment for anti-MuSK myasthenia gravis 2017 ·Neurology ·Michael K. Hehir, Lisa D. Hobson‐Webb, Michael Benatar, Carolina Barnett, Nicholas J. Silvestri, James F. Howard, Diantha B. Howard, Amy Visser, Brian A. Crum, Richard J. Nowak, Rachel Beekman, Aditya Kumar, Katherine Ruzhansky, I-Hweii A. Chen, Michael Pulley, (unknown), Melissa Fellman, (unknown), Mamatha Pasnoor, Ted M. Burns	166
14	A Bayesian comparative effectiveness trial in action: developing a platform for multisite study adaptive randomization 2016 ·Trials ·Alexandra R. Brown, Byron J. Gajewski, Lauren S. Aaronson, Dinesh Pal Mudaranthakam, Suzanne Hunt, Scott Berry, Melanie Quintana, Mamatha Pasnoor, Mazen M. Dimachkie, Omar Jawdat, Laura Herbelin, Richard J. Barohn	17
15	Aerobic exercise improves measures of vascular health in diabetic peripheral neuropathy 2016 ·International Journal of Neuroscience ·Sandra A. Billinger, (unknown), Abdulfattah S. Alqahtani, Mamatha Pasnoor, Patricia M. Kluding	24
16	Stiff Person Syndrome: A case series (P7.053) 2015 ·Neurology ·Duaa Jabari, Mazen M. Dimachkie, Jeffrey Statland, Ahmad R. Abuzinadah, Omar Jawdat, Melanie Glenn, April McVey, Arthur Dick, Richard Dubinsky, Laura Herbelin, Richard J. Barohn, Mamatha Pasnoor	0
17	Diabetic Neuropathy Part 1 2013 ·Neurologic Clinics ·Mamatha Pasnoor, Mazen M. Dimachkie, Patricia M. Kluding, Richard J. Barohn	68
18	Benefit of Qigong Exercise in Patients With Fibromyalgia: A Pilot Study 2012 ·International Journal of Neuroscience ·Wen Liu, (unknown), (unknown), (unknown), Jessica Ratner, Yunxia Wang, Mamatha Pasnoor, Mazen M. Dimachkie, Richard J. Barohn	48
19	Autonomic nerve function in adult patients with cyclic vomiting syndrome 2011 ·Neurogastroenterology & Motility ·Reza Hejazi, Teri Lavenbarg, Mamatha Pasnoor, Mazen M. Dimachkie, Pernilla Foran, Laura Herbelin, Richard W. McCallum	32
20	MRI tissue characterization of experimental cerebral ischemia in rat 2003 ·Journal of Magnetic Resonance Imaging ·Hamid Soltanian‐Zadeh, Mamatha Pasnoor, Rabih Hammoud, Michael A. Jacobs, Suresh Patel, Panayiotis Mitsias, Robert A. Knight, (unknown), Mei Lü, Michael Chopp	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact